Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy.

Autor:	Azzam NA; Division of Gastroenterology, Department of Medicine, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia., Almutairdi A; Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Almudaiheem HY; Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia., AlAmeel T; Department of Medicine, King Fahad Specialist Hospital, Dammam, Saudi Arabia., Bakkari SA; Department of Gastroenterology, King Saud Medical City, Riyadh, Saudi Arabia., Alharbi OR; Division of Gastroenterology, Department of Medicine, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia., Alenzi KA; Executive Director of Transformation, Planning, and Business Development, Tabuk Health Cluster, Tabuk, Saudi Arabia., AlMolaiki MA; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Al-Omari BA; Department of Pharmaceutical Care Services, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Albarakati RG; Department of Obstetrics and Gynecology, Majmaah University, Riyadh, Saudi Arabia., Al-Jedai AH; Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia.; Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Riyadh, Saudi Arabia., Saadah OI; Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Inflammatory Bowel Disease Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia., Almadi MA; Division of Gastroenterology, Department of Medicine, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia., Al-Bawardy B; Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.; Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, CT, USA., Mosli MH; Department of Internal Medicine, King Abdulaziz University, Inflammatory Bowel Disease Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Jazyk:	angličtina
Zdroj:	Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association [Saudi J Gastroenterol] 2023 Dec 15. Date of Electronic Publication: 2023 Dec 15.
DOI:	10.4103/sjg.sjg_318_23
Abstrakt:	Abstract: The management of inflammatory bowel disease (IBD) in pregnant women is challenging and must be addressed on a patient-by-patient basis. Optimal patient management requires a multidisciplinary team and clear evidence-based recommendations that cater to this subset of patients. In this article, we provide concise guidelines and clinical care pathway for the management of IBD in pregnant women. Our recommendations were developed by a multidisciplinary working group that includes experts from the Saudi Ministry of Health in collaboration with the Saudi Gastroenterology Association and the Saudi Society of Clinical Pharmacology. All recommendations are based on up-to-date information following an extensive literature review. A total of 23 evidence-based expert opinion recommendations for the management of IBD in pregnant women are herein provided. (Copyright © 2023 Copyright: © 2023 Saudi Journal of Gastroenterology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu